EP 3761863 A1 20210113 - COGNITIVE SCREENS, MONITOR AND COGNITIVE TREATMENTS TARGETING IMMUNE-MEDIATED AND NEURO-DEGENERATIVE DISORDERS
Title (en)
COGNITIVE SCREENS, MONITOR AND COGNITIVE TREATMENTS TARGETING IMMUNE-MEDIATED AND NEURO-DEGENERATIVE DISORDERS
Title (de)
KOGNITIVE SCREENINGS, MONITORE UND KOGNITIVE BEHANDLUNGEN, DIE AUF IMMUNVERMITTELTE UND NEURODEGENERATIVE ERKRANKUNGEN ABZIELEN
Title (fr)
ÉCRANS COGNITIFS, MONITEUR ET TRAITEMENTS COGNITIFS CIBLANT DES TROUBLES À MÉDIATION IMMUNITAIRE ET NEURODÉGÉNÉRATIFS
Publication
Application
Priority
- US 201862638299 P 20180304
- US 201862744063 P 20181010
- US 2019020508 W 20190304
Abstract (en)
[origin: WO2019173189A1] Systems and methods for generating a personalized cognitive treatment recommendation for an individual. The system includes one or more processors; and a memory to store processor-executable instructions. Upon execution of the instructions, the one or more processors receive parameters for at least one cognitive treatment tool; receive physiological data indicative of a condition of the individual, and/or clinical data associated with the individual; and generate the personalized cognitive treatment recommendation based on the physiological data and/or the clinical data. The recommendation includes a specification of (i) at least one first cognitive treatment tool, (ii) at least one second cognitive treatment tool different from the at least one first cognitive treatment tool, or (iii) both (i) and (ii). Optionally, the one or more processors receive performance data indicative of the individual's performance of at least one task associated with the at least one cognitive treatment tool of the recommendation.
IPC 8 full level
A61B 5/00 (2006.01)
CPC (source: EP KR)
A61B 5/0002 (2013.01 - KR); A61B 5/1124 (2013.01 - EP KR); A61B 5/163 (2017.07 - KR); A61B 5/165 (2013.01 - EP KR); A61B 5/4088 (2013.01 - KR); A61B 5/4836 (2013.01 - EP KR); A61B 5/7465 (2013.01 - KR); A61M 21/00 (2013.01 - KR); A61M 21/02 (2013.01 - KR); G16H 20/70 (2017.12 - EP KR); G16H 50/20 (2017.12 - EP); G16H 50/30 (2017.12 - EP); A61B 5/0205 (2013.01 - EP); A61B 5/163 (2017.07 - EP); A61B 5/369 (2021.01 - EP); A61B 5/4082 (2013.01 - EP); A61B 5/4088 (2013.01 - EP); A61B 5/7475 (2013.01 - EP); A61B 2505/09 (2013.01 - KR); A61M 2021/0022 (2013.01 - KR); A61M 2021/0027 (2013.01 - KR); A61M 2021/0044 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019173189 A1 20190912; AU 2019229979 A1 20200924; CA 3093252 A1 20190912; CN 112040844 A 20201204; EP 3761863 A1 20210113; EP 3761863 A4 20220406; JP 2021516099 A 20210701; KR 20200128555 A 20201113; TW 201944429 A 20191116
DOCDB simple family (application)
US 2019020508 W 20190304; AU 2019229979 A 20190304; CA 3093252 A 20190304; CN 201980029489 A 20190304; EP 19764469 A 20190304; JP 2020546125 A 20190304; KR 20207028297 A 20190304; TW 108107129 A 20190304